Patients were initially randomized to a daily , moderate-intensity ( atorvastatin -LSB- @ mg -RSB- , simvastatin -LSB- @ mg -RSB- , or rosuvastatin -LSB- @ mg -RSB- ) or high-intensity ( atorvastatin -LSB- @ mg -RSB- , rosuvastatin -LSB- @ mg -RSB- ) statin .